New Delhi, Drug Controller General Of India (DCGI) gave a restricted emergency use approval to the Zydus Cadila’s ‘Virafin’ for treating the patients showing moderate COVID-19 symptoms. Virafin is a …
Zydus’ Virafin gets emergency nod for treating moderate Covid-19 infections Read More
New Delhi: Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 — ZyCoV-D — was found to be safe and well tolerated in the phase …
Covid-19 vaccine: Zydus Cadila to begin phase-2 clinical trials Read More
New Delhi: Four days after successfully developing the first indigenous anti-SARS-CoV-2A (Covid-19) human IgG ELISA test kit for antibody detection of the deadly virus, the ICMR on Thursday said that the …
ELISA kits produced by Zydus Cadila has 98% sensitivity: ICMR Read More
